Streptococcus mitis

Streptococcus mitis. It is a Gram-positive, facultatively anaerobic member of the viridans streptococci group, commonly found as a commensal in the human oral cavity and oropharynx. This alpha-hemolytic species is a pioneer colonizer of the tooth surface and mucosal epithelia, playing a complex role in both maintaining oral health and acting as an opportunistic pathogen. Its clinical importance is most pronounced in immunocompromised individuals, where it is a leading cause of infective endocarditis and bacteremia, particularly following cytotoxic chemotherapy.

Description and classification

*Streptococcus mitis* is a catalase-negative, non-motile coccus that typically forms chains or pairs. It is classified within the Mitis group of the viridans streptococci, a taxonomic cluster that also includes species like *Streptococcus oralis* and *Streptococcus pneumoniae*. Historically, its classification was challenging due to phenotypic similarities with close relatives, but modern techniques like multilocus sequence analysis and 16S rRNA gene sequencing have refined its phylogenetic placement. The species exhibits significant genomic diversity, with strains like ATCC 49456 serving as important reference genomes for research. It is distinguished from the closely related and highly pathogenic *Streptococcus pneumoniae* by its absence of a polysaccharide capsule and its resistance to optochin.

Habitat and transmission

The primary ecological niche for *Streptococcus mitis* is the human oral mucosa, dental plaque, and oropharynx, where it is among the first bacteria to colonize infants. It is a ubiquitous component of the normal human microbiota, also frequently found in the nasopharynx and gastrointestinal tract. Transmission occurs through direct contact with saliva or respiratory droplets, a common route within families or in settings like daycare centers. Its establishment and persistence are facilitated by its ability to adhere to oral surfaces and to co-aggregate with other early colonizers like *Actinomyces naeslundii*.

Clinical significance

While typically a harmless commensal, *Streptococcus mitis* is a major opportunistic pathogen. It is a predominant cause of infective endocarditis, often following transient bacteremia from dental procedures like tooth extraction or periodontal surgery. In patients with neutropenia, especially those undergoing treatment for acute myeloid leukemia at centers like the MD Anderson Cancer Center, it is a frequent cause of severe bacteremia and sepsis. It is also implicated in other infections including meningitis, pneumonia, and septic arthritis, particularly in individuals with compromised immune systems or prosthetic devices.

Virulence factors

The pathogenicity of *Streptococcus mitis* is mediated by an array of surface-exposed and secreted factors that promote colonization and immune evasion. Key adhesins include pili and antigen I/II family proteins that facilitate binding to host extracellular matrix proteins like fibrinogen and fibronectin. It produces an exopolysaccharide glucan that contributes to biofilm formation on heart valves. Some strains possess a gene homologous to the *pneumolysin* gene of *Streptococcus pneumoniae*, encoding a putative cytotoxin. Furthermore, its ability to acquire antibiotic resistance genes, including those conferring resistance to penicillin and macrolides, via horizontal gene transfer from other streptococci enhances its survival in clinical settings.

Diagnosis and treatment

Diagnosis relies on culturing the bacterium from normally sterile sites such as blood or cerebrospinal fluid. In the clinical microbiology laboratory, it is identified by its alpha-hemolysis on blood agar, negative reaction to optochin and bile solubility tests, and pattern of carbohydrate fermentation. Automated systems like the VITEK 2 or MALDI-TOF mass spectrometry are commonly used for definitive species identification. Treatment is complicated by increasing antibiotic resistance; while penicillin G remains a cornerstone for susceptible strains, the emergence of penicillin-resistant and vancomycin-tolerant isolates necessitates susceptibility testing. Combination therapy with an aminoglycoside like gentamicin is often recommended for serious infections like endocarditis.

Research and applications

Research on *Streptococcus mitis* focuses on its role as a model organism for studying oral biofilm development, horizontal gene transfer, and commensal-pathogen transitions. Its genome, such as that of strain NCTC 12261, is studied for insights into evolution, particularly its relationship with *Streptococcus pneumoniae*. Investigations led by institutions like the Wellcome Sanger Institute explore its population structure and the mobilization of resistance genes. Furthermore, its surface proteins are investigated for potential use in vaccines to protect against broader viridans streptococci infections. Its ubiquitous presence and genetic tractability also make it a candidate for developing oral probiotic delivery systems.